# Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective Randomized Trial

> **NCT03247101** · NA · UNKNOWN · sponsor: **Min-Sheng General Hospital** · enrollment: 180 (estimated)

## Conditions studied

- Clostridium Butyricum Miyairi
- Gallstones
- Gastrointestinal Quality of Life Index

## Interventions

- **DRUG:** Miyarisan-BM (Clostridium Butyricum Miyairi)
- **DRUG:** Urso group
- **DRUG:** Biotase group

## Key facts

- **NCT ID:** NCT03247101
- **Lead sponsor:** Min-Sheng General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2017-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03247101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03247101, "Probiotics for Gallstones in Post-bariatric Surgery Patients：A Prospective Randomized Trial". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03247101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*